Sionna Therapeutics, Inc. (SION)
Nasdaq: SION · Pharmaceutical Preparations · Waltham, MA · filing with the SEC since 2024
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 |
|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 |
| Report filed | Mar 2, 2026 | Mar 20, 2025 |
| Research and development | 60,263 | 57,288 |
| General and administrative | 28,719 | 13,268 |
| Total operating expenses | 88,982 | 70,556 |
| Operating income | -88,982 | -70,556 |
| Interest and investment income | 13,295 | 8,170 |
| Total non-operating income (expense) | 13,714 | 8,868 |
| Income tax expense | 0 | 0 |
| Net income | -75,268 | -61,688 |
| Earnings per share, basic | -1.88 | -15.99 |
| Earnings per share, diluted | -1.88 | -15.99 |
| Weighted average shares, basic | 39,962,163 | 3,858,859 |
| Weighted average shares, diluted | 39,962,163 | 3,858,859 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding